New Advances in Melanoma

Melanoma is a very aggressive tumor which is derived from the transformation of pigment-producing cells termed the melanocytes. This cancer type accounts for most of the deaths associated with skin cancer as well as its incidence and is in constant evolution. Because of the rapid and very high metas...

Full description

Bibliographic Details
Main Author: Larribère, Lionel
Format: eBook
Language:English
Published: Basel MDPI - Multidisciplinary Digital Publishing Institute 2022
Subjects:
Nf1
Online Access:
Collection: Directory of Open Access Books - Collection details see MPG.ReNa
LEADER 03382nma a2200673 u 4500
001 EB002043698
003 EBX01000000000000001187364
005 00000000000000.0
007 cr|||||||||||||||||||||
008 220822 ||| eng
020 |a 9783036534534 
020 |a 9783036534541 
020 |a books978-3-0365-3454-1 
100 1 |a Larribère, Lionel 
245 0 0 |a New Advances in Melanoma  |h Elektronische Ressource 
260 |a Basel  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2022 
300 |a 1 electronic resource (148 p.) 
653 |a incidence 
653 |a druggable mutations 
653 |a single-cell transcriptome sequencing 
653 |a RNAseq 
653 |a transcriptome 
653 |a animal models 
653 |a Public health & preventive medicine / bicssc 
653 |a miRNAs 
653 |a targeted therapies 
653 |a pseudotime analysis 
653 |a skin cancer 
653 |a melanoblasts 
653 |a transporter associated with antigen processing 
653 |a Trp-1 
653 |a melanoblast 
653 |a embryogenesis 
653 |a lung 
653 |a immune escape 
653 |a mice 
653 |a treatment 
653 |a melanoma 
653 |a ubiquitination 
653 |a metastasis 
653 |a BRAF 
653 |a NGS assay 
653 |a real-time PCR 
653 |a population-based study 
653 |a NF1 
653 |a treatment response 
653 |a epidemiology 
653 |a Spain 
653 |a microRNA 
700 1 |a Larribère, Lionel 
041 0 7 |a eng  |2 ISO 639-2 
989 |b DOAB  |a Directory of Open Access Books 
500 |a Creative Commons (cc), https://creativecommons.org/licenses/by/4.0/ 
024 8 |a 10.3390/books978-3-0365-3454-1 
856 4 2 |u https://directory.doabooks.org/handle/20.500.12854/81094  |z DOAB: description of the publication 
856 4 0 |u https://www.mdpi.com/books/book/5123  |x Verlag  |3 Volltext 
082 0 |a 610 
082 0 |a 380 
520 |a Melanoma is a very aggressive tumor which is derived from the transformation of pigment-producing cells termed the melanocytes. This cancer type accounts for most of the deaths associated with skin cancer as well as its incidence and is in constant evolution. Because of the rapid and very high metastatic potential of this tumor, melanoma prognosis has been quite poor for a long time. In the past decade, groundbreaking discoveries in the melanoma research field have led to the development of two main treatment strategies: combination therapies targeting specific kinases or combination therapies focused on immune checkpoint inhibitors (ICIs). These treatment approaches have become the standard of care in most cancer centers and significantly improved the prognosis and overall survival of advanced melanoma patients. Nevertheless, many patients do not benefit from or even respond to these treatments. It is therefore essential to better comprehend the phenomenon of drug resistance, immune escape mechanisms, as well as to search for alternative treatment strategies. In addition, strong predictive biomarkers are desperately needed to improve clinical efficacy. The aim of this Special Issue is to present recent advances in the field of melanoma research, in which the abovementioned areas represent the primary focus, and other relevant themes are also discussed.